Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing

Recruiting now

Conditions studied: Cancer

In brief

Key facts

Study ID: NCT02090530
Run by: Ohio State University Comprehensive Cancer Center
People needed: 1000
Starts: 2013-11-04
Expected to finish: 2027-12-31
Last updated by the study team: 2026-04-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

A histologically or cytologically confirmed diagnosis of cancer
Patients with any malignancy.
Patients must have tumor suitable for research tumor biopsy (as assessed by trained specialists in interventional radiology) and Patients are medically fit to undergo a tissue biopsy or surgical procedure to get tumor tissue OR If Patients do not have a tumor suitable for biopsy but have another tissue available for molecular evaluation.
OR Patients are undergoing standard of care surgeries or procedures where fresh specimens will be first used for routine pathologic assessment and only then will leftover tissue be used for research purposes.
Procedure-specific signed informed consent prior to initiation of any study-related procedures.
Women and minorities are included in this protocol.
Patients with multiple malignancies remain eligible.
Patients with an inherited cancer syndrome or a medical history suggestive of an inherited cancer syndrome remain eligible.

You may not qualify if…

It is the enrolling study physicians discretion to decide if a patient is not fit enough to undergo tissue biopsy.
Patients who are incarcerated are not eligible to participate.

Where it is running

Ohio State University Wexner Medical Center — Columbus, Ohio, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.